Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Gallagher

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer|July 17, 2008
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line settingDavid J Gallagher, Matthew I Milowsky, Dean F Bajorin
Oncology (Williston Park, N.Y.)|July 31, 2010
Genome-wide association studies of cancer: principles and potential utilityZsofia K Stadler, David J Gallagher, Peter Thom, et al.
Clinical Colorectal Cancer|October 6, 2010
Diagnosing hereditary colorectal cancerDavid J Gallagher, James D Smith, Kenneth Offit, et al.
Surgical Oncology|June 21, 2015
An overview of triple negative breast cancer for surgical oncologistsShiva Sharma, Mitchel Barry, David J Gallagher, et al.
Journal of Surgical Oncology|April 26, 2016
Young patients with synchronous colorectal liver metastasesJames D Smith, Maeve A Lowery, David Fell, et al.
JCO Precision Oncology|January 11, 2024
Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-AnalysisRobert F Power, Damien E Doherty, Imelda Parker, et al.
Hereditary Cancer in Clinical Practice|June 14, 2024
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional surveyRobert F Power, Damien E Doherty, Roberta Horgan, et al.
The Cochrane Database of Systematic Reviews|June 1, 2026
Risk prediction models for familial breast cancerSarah A McGarrigle, Yvonne P Hanhauser, David Mockler, et al.
BJU International|July 16, 2011
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancerDavid J Gallagher, Angel M Cronin, Matthew I Milowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II study of sunitinib in patients with metastatic urothelial cancerDavid J Gallagher, Matthew I Milowsky, Scott R Gerst, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer|July 17, 2008
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line settingDavid J Gallagher, Matthew I Milowsky, Dean F Bajorin
Oncology (Williston Park, N.Y.)|July 31, 2010
Genome-wide association studies of cancer: principles and potential utilityZsofia K Stadler, David J Gallagher, Peter Thom, et al.
Clinical Colorectal Cancer|October 6, 2010
Diagnosing hereditary colorectal cancerDavid J Gallagher, James D Smith, Kenneth Offit, et al.
Surgical Oncology|June 21, 2015
An overview of triple negative breast cancer for surgical oncologistsShiva Sharma, Mitchel Barry, David J Gallagher, et al.
Journal of Surgical Oncology|April 26, 2016
Young patients with synchronous colorectal liver metastasesJames D Smith, Maeve A Lowery, David Fell, et al.
JCO Precision Oncology|January 11, 2024
Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-AnalysisRobert F Power, Damien E Doherty, Imelda Parker, et al.
Hereditary Cancer in Clinical Practice|June 14, 2024
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional surveyRobert F Power, Damien E Doherty, Roberta Horgan, et al.
The Cochrane Database of Systematic Reviews|June 1, 2026
Risk prediction models for familial breast cancerSarah A McGarrigle, Yvonne P Hanhauser, David Mockler, et al.
BJU International|July 16, 2011
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancerDavid J Gallagher, Angel M Cronin, Matthew I Milowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II study of sunitinib in patients with metastatic urothelial cancerDavid J Gallagher, Matthew I Milowsky, Scott R Gerst, et al.
Pageof 4